AUPH vs PHVS: stock comparison and AI forecast
Aurinia Pharmaceuticals Inc. (AUPH) and Pharvaris N.V. (PHVS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AUPH Aurinia Pharmaceuticals Inc.
- Market Cap
- $2.22B
- P/E Ratio
- 8.0x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
PHVS Pharvaris N.V.
- Market Cap
- $2.19B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AUPH and PHVS have similar market capitalizations ($2.22B and $2.19B).
- AUPH carries 0.26 times debt per unit of equity, against 0.14 times for PHVS.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AUPH | PHVS |
|---|---|---|
| Market Cap | $2.22B | $2.19B |
| P/E Ratio | 8.04x | – |
| P/B Ratio | 3.37x | – |
| EPS | $2.07 | $-2.60 |
| Book Value/Share | $4.94 | – |
| Revenue/Share | $2.42 | – |
| FCF/Share | – | $-3.31 |
Profitability & Margins
| Metric | AUPH | PHVS |
|---|---|---|
| ROE | 47.8% | – |
| ROA | 38.1% | – |
| ROIC | 21.4% | – |
| Gross Margin | 90.6% | – |
| Operating Margin | 48.6% | – |
| Net Margin | 97.7% | – |
| EBT Margin | 51.9% | – |
| Tax Rate | -88.0% | -1.4% |
Financial Health
| Metric | AUPH | PHVS |
|---|---|---|
| Current Ratio | 6.12x | – |
| Quick Ratio | 5.67x | – |
| D/E Ratio | 0.26x | 0.14x |
| Financial Leverage | 1.26x | 1.14x |
| Working Capital | $492M | – |
Cash Flow
| Metric | AUPH | PHVS |
|---|---|---|
| Operating Cash Flow | $177M | -$215M |
| Free Cash Flow | – | -$216M |
| Capital Spending | – | -$350K |
| OCF Growth YoY | 47.5% | – |
Operational Efficiency
| Metric | AUPH | PHVS |
|---|---|---|
| Asset Turnover | 0.39x | – |
| Inventory Turnover | 0.7x | – |
| Fixed Assets Turnover | 185.2x | – |
| Days Inventory | 529 days | – |
| Payables Period | 36 days | – |
Income Statement
| Metric | AUPH | PHVS |
|---|---|---|
| Total Revenue | $322M | – |
| Operating Income | $156M | -$116M |
| Net Income | $314M | – |
| R&D Expense | $48M | $88M |
| Cost of Goods Sold | $30M | – |
Dividend & Shareholder Information
| Metric | AUPH | PHVS |
|---|---|---|
| Shares Outstanding | 133M | 65M |
| Net Income Growth | 303.8% | – |
| EPS Growth | 1117.7% | – |
AUPH vs PHVS: stock comparison and AI forecast
Which is bigger, AUPH or PHVS?
AUPH and PHVS have similar market capitalizations ($2.22B and $2.19B).
Which one does Intratio's AI model rank higher, AUPH or PHVS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.